Interventions to Improve HIV Antiretroviral Therapy Adherence
NCT ID: NCT03618511
Last Updated: 2021-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
914 participants
INTERVENTIONAL
2018-08-06
2021-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments
NCT05110963
Behavioral Economics Incentives to Support HIV Treatment Adherence in Sub-Saharan Africa
NCT03494777
ENGAGE4HEALTH: A Combination Intervention Strategy for Linkage and Retention in Mozambique
NCT01930084
Supporting Sustained HIV Treatment Adherence After Initiation
NCT05040841
Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral Therapy
NCT03351556
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Financial Incentive Group
Financial Incentive
Financial Incentive: Participants will receive monthly financial incentives each time they refill the ART medication on time for six months
Reminders Group
Reminders
Reminders: Participants will receive monthly reminder phone calls before their ART medication refill is due for six months.
Financial Incentive and Reminders Group
Financial Incentive and Reminders
Interaction: Participants receive both the Financial Incentives and Reminder Calls.
Control Group
No interventions assigned to this group
Information Group
Information
Information: show the participants a video about HIV progression, mechanism of ART, the benefit of adhering to ART.
Stigma-relieving Group
Stigma-relieving
Stigma-Reliving: Upon recruitment, inform the participants of the results of a recent population survey regarding people's attitudes towards HIV, if they overestimate the social stigma related to HIV. This intervention intends to reduce the stigma-concern faced by the patients.
Information and Stigma-relieving Group
Information and Stigma-relieving
Information and Stigma-relieving: Upon recruitment, show the participants a video about HIV progression, mechanism of ART, the benefit of adhering to ART. In addition, inform the participants of the results of a recent population survey regarding people's attitudes towards HIV, if they overestimate the social stigma related to HIV. This intervention intends to reduce the stigma-concern faced by the patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Financial Incentive
Financial Incentive: Participants will receive monthly financial incentives each time they refill the ART medication on time for six months
Reminders
Reminders: Participants will receive monthly reminder phone calls before their ART medication refill is due for six months.
Financial Incentive and Reminders
Interaction: Participants receive both the Financial Incentives and Reminder Calls.
Information
Information: show the participants a video about HIV progression, mechanism of ART, the benefit of adhering to ART.
Stigma-relieving
Stigma-Reliving: Upon recruitment, inform the participants of the results of a recent population survey regarding people's attitudes towards HIV, if they overestimate the social stigma related to HIV. This intervention intends to reduce the stigma-concern faced by the patients.
Information and Stigma-relieving
Information and Stigma-relieving: Upon recruitment, show the participants a video about HIV progression, mechanism of ART, the benefit of adhering to ART. In addition, inform the participants of the results of a recent population survey regarding people's attitudes towards HIV, if they overestimate the social stigma related to HIV. This intervention intends to reduce the stigma-concern faced by the patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have not start ART, or started ART less than 90 days before;
* Have a phone number on which can discuss private health matters.
Exclusion Criteria
* On ART for more than 90 days;
* Do not have a private phone.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beira Operational Research Center
UNKNOWN
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James Riddell
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James Riddell IV, MD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Munhava Health Center
Beira, Sofala, Mozambique
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00133179
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.